The development of proliferative verrucous leukoplakia in oral lichen planus: a preliminary study by García-Pola Vallejo, M.J. et al.
Med Oral Patol Oral Cir Bucal. 2016 May 1;21 (3):e328-34.                                                                                                                                                    Proliferative verrucous oral lichen planus
e328
Journal section: Oral Medicine and Pathology
Publication Types: Research
The development of proliferative verrucous leukoplakia 
in oral lichen planus. A preliminary study
María-José  Garcia-Pola 1,  Santiago  Llorente-Pendás  2,   Manuel  González-Garcia  3,   José-Manuel   García-Martín 4
1 Associate Professor of Oral Medicine. Faculty of Medicine. Catedrático José Serrano. 33006. Oviedo University. Spain
2 Medical Doctor. Oral and Maxillofacial Surgeon. Private practice of Oral and Maxillofacial Surgery. Medical Director of Head 
and Neck Center. Pérez de la Sala 37.33007. Oviedo. Spain 
3 Assistant Professor of Oral and Maxillofacial Surgery. Faculty of Medicine. Catedrático José Serrano. 33006. Oviedo Univer-
sity. Spain 
4 Assistant Professor of Oral Health & Preventive Dentistry. Faculty of Medicine. Catedrático José Serrano. 33006. Oviedo Uni-
versity. Spain 
Correspondence:
Faculty of Medicine
Catedrático José Serrano
33006. Oviedo Spain
mjgarcia@uniovi.es
Received: 17/05/2015
Accepted: 27/01/2016
Abstract
Background: Was to describe 14 cases of a proliferative verrucous leukoplakia as a clinical evolution of oral 
lichen planus.
Material and Methods: The clinical and histopathological characteristics of 14 cases of OLP that progress towards 
a plaque-like and verrucous form were indicated, with monitoring over a period of six to 24.3 years.
Results: The female/male ratio was 11/3, (78.6 and 21.4%). The mean age when the first biopsy was undertaken 
was 56.4 years old. None of the patients smoked during the study. As bilateral reticular was clinically diagnostic 
criterion, the second most frequent clinical form was the plaque form (n=10; 71.4%), followed by the atrophic (n=6; 
42.8%), and erosive forms (n=4; 28.5%). Clinically it spread towards attached gingival mucosa and the hard palate. 
In the histopathologic study, there were a predominance of hyperkeratosis and verrucous epithelial hyperplasia. 
Three of the cases progressed to a squamous cell carcinoma, and one patient developed two verrucous carcino-
ma.
Conclusions: Further research is needed to demonstrate if proliferative multifocal oral lichen planus and prolife-
rative multifocal oral leukoplakia are the same disorder but have different behaviour of malignancy for reasons 
of origin.
Key words: Oral lichen planus, proliferative verrucous oral leukoplakia, malignant oral lichen planus, multifocal 
verrucous oral lichen planus, proliferative verrucous oral lichen planus.
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Introduction
Oral lichen planus and oral leukoplakia are the most 
common potentially malignant disorders. Oral lichen 
planus (OLP) is a chronic, autoimmune mucocutaneous 
disease, characterised by exacerbation and remission pe-
riods. OLP can present as white papules that gradually 
expand in a symmetrical manner to form a reticular pat-
tern (Wickham’s striae), or as plaques, which may or may 
not come with atrophic, erosive, and bullous forms (1). 
Although oral leukoplakia (OL) has been defined as “pre-
dominantly white lesion of the oral mucosal that cannot 
be characterized as other definable lesion” (2), in some 
OLP patients, gingival location presenting as white papu-
les or plaques may resemble leukoplakia (3). Even may at 
times be difficult to distinguish clinically from homoge-
neous and non-homogeneous leukoplakia (4).
The risk of development oral cancer in OLP patients 
has been the issue of much debate. The rate of trans-
formation in individual studies ranged from 0 to 3.5% 
(5). The literature reveals that there may be a higher 
frequency of OLP transforming into squamous cell car-
cinoma in some locations, such as tongue, followed by 
buccal mucosa and gingival. With respect to the clinical 
form, results are somewhat arduous to interpret because 
carcinoma may be preceded by atrophic-erosive (6-8), 
non-erosive (9), in other series by plaque form (10), and 
finally there are published works that found equally 
atrophic-erosive or plaque form (11,12). 
In 1985 Hansen et al. introduced a new subtype of 
OL designed as “proliferative verrucous leukoplakia” 
(PVL) (13). PVL is differentiated by slow-growing and 
progressive clinical course, with changes clinical and 
histopathologic. PVL is an aggressive form of oral leu-
koplakia with considerable morbidity and strong predi-
lection to malignant transformation (14).
Guideline or protocols of diagnostic criteria have been 
published to provide diagnosis of PVL (15-17). In or-
der to make the early and rapid diagnosis of PVL Ce-
rero et al. (17) have suggested major and minor criteria 
that offer a great support, emphasizing the presence of 
histopathologic pattern such as hyperkeratosis verru-
cous hyperplasia or carcinoma.
Our aim was to describe the behaviour of oral lichen 
planus patients, characterised for presenting a clinical 
form that progressed to a proliferative verrucous pla-
que-like pattern, and monitored for a minimum period 
of six years by the same workgroup.
Material and Methods
This descriptive observational study was conducted 
from a cohort of patients diagnosed of OLP, between 
September 1984 and February 2015. OLP patients were 
diagnosed by the same author clinically and by biopsy, 
based on the World Health Organization (WHO) criteria 
in 1978 (18) and on the criteria proposed by van der Meij 
and van der Waal in 2003 (1). The following requisites 
must be fulfilled: bilateral papules and reticular present, 
which may or may not come with other clinical forms 
of OLP (plaque, atrophic, erosive, bullous), and a histo-
logical description of band-like inflammatory infiltrate 
in the subbasal layer, liquefaction degeneration in the 
basal layer, and no dysplasia. 
From OLP patients we included in the present study, tho-
se patients with the following progression behaviour: 1) 
predominating plaque-like form in almost a topographi-
cal area, with roughness and thickening, white-greyish 
in colour or verrucous form, 2) spreading multifocal 
growth affecting more than two oral locations and in-
cluding the attached mucosa (gingival, alveolar process 
in edentulous area) or the hard palate, buccal or lingual 
mucosa, 3) histological criterion, through a second 
biopsy on the plaque-like or verrucous areas, with the 
presence of hyperkeratosis, acanthosis, papillomatous, 
or hyperplasia, without band-like inflammatory infil-
trate (or without dominance), 4) treatment resistant, 5) 
monitoring for at least 5 years by the same doctor. 
The studied variable were: gender, age, toxic habits 
(smoking, alcohol, and narcotics), location of the OLP, 
clinical form of OLP, affectation of other mucosa, 
appendages and skin, length of the monitoring, OLP 
treatment, microscopic changes in the second biopsy, 
and type of malignancy, number of carcinomas develo-
ped and their respective treatments.
The medical treatment options for OLP were: 1) Topical 
corticosteroids (TC) with 0.05% Clobetasol Propionate 
in Orabase and in aqueous solution; 2) daily oral admin-
istration of prednisone (0.5 mg/kg weight/day) followed 
by every other day; 3) acitretin 25-50 mg/day orally; 4) 
topical retinoids 0.1% 13-cis-retinoic acid in orabase. 
The excision treatment involved an intervention using 
a scalpel and CO2 laser surgery. The laser wavelength 
was 10.600nm and the vaporisation occurred between 
4.5-7W. Treatments for the carcinomas included scalpel 
surgery, radiotherapy and laser CO2. Nystatin and fluco-
nazole were used as an adjuvant treatment for compli-
cated cases with secondary oral candidosis.
This project was approved by the Ethics in Research 
Committee from the University Central Hospital of As-
turias.
Results
Between years mentioned we recruitment a total of 515 
oral lichen planus, from those, we collected a total of 
14 patients (2.7%) that development proliferative verru-
cous leukoplakia.
The details of the demographic study for each of the 14 
patients are summarised in table 1 and table 1 Conti-
nue. The patients were monitored for a minimum of 6.3 
years and a maximum of 24.3 years, with a mean follow 
up time of 14.5 years. 
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The female/male ratio was 11/3, (78.6 and 21.4%). The 
mean age when the first biopsy was undertaken was 56.4 
years old, 58.5 years old and 48.6 years old for women 
and men respectively.
None of the patients smoked or took narcotics during 
the study. Three were ex-cigarette smokers of more than 
15 years. Three male patients drank one or two glasses 
of wine at the weekend. The women did not drink.
The predominant initial clinical together bilateral reti-
cular form was the plaque form (n=10; 71.4%), followed 
by the atrophic (n=6; 42.8%), and erosive forms (n=4; 
28.5%).
The most common location at baseline was the bilateral 
buccal mucosa (n=11; 78.5%), followed by the gingiva 
and palate mucosa (n=11; 78.5%), and the lingual muco-
sa (n=3; 21.4). They all had three or more affected areas 
(Fig. 1). Only two female patients had affected skin, 
which responded positively to treatment with topical 
corticosteroids.
The initial OLP treatment was topical corticosteroids in 
all cases. The remaining treatment options for each pa-
tient are detailed in table 1 and table 1 Continue. The pa-
tients did not show adverse haematological reactions. 
During the follow-up of patients, nine of them acquired 
clinical forms different from the initial (Fig. 2). Since 
the time of diagnosis, the mean time for developing 
plaque-like and multifocal verrucous lesions as the pre-
dominant lesion was 4 years (Fig. 3). 
Hyperkeratosis (parakeratin and or orthokeratin) was 
present in part of all specimens, acanthosis and papi-
llomatous squamous proliferation partly in ten cases, 
and verrucous hyperplasia in nine cases. Four patients 
(28.5%) went on to become malignant, three cases of 
squamous cell carcinoma (SCC) were well-differentia-
ted, and one verrucous carcinoma. The mean time to 
malignant transformation from the first diagnosis was 9 
years. Three cases were female and one male. The most 
common location of carcinoma was attachment mucosa 
(Fig. 4), gingival and hard palate.
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Fig. 1. Reticular, plaque and atrophic type of lichen planus in hard 
palate, and reticular-erosive in buccal mucosa at the moment of di-
agnosis. 
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Discussion
In the present study we describe the characteristics of 
PVL in patients previously diagnosed of oral lichen pla-
nus, contributing to corroborate what in recent reports 
have suggested, the clinical relationship between OLP 
and PVL (19) and the presence of local histopatholo-
gic pattern with lymphocytic infiltrate in some areas of 
PVL (20)
The exact prevalence of PVL is not well known, most 
cases reported about long time series, its appearance, 
behaviour, treatment and malignant transformation. 
In our study we present, from a set of OLP diagnosed 
at first visit by the same professional, a total of 2.7% 
patients that suffered clinical and histopathologic chan-
ges towards PVL. Brzak et al. (21) contributed data of 
0.15% OLP joints OL in a sample that was performed 
during ten years. To avoid future discrepancies, our fi-
gures did not include patients who had the first day OL 
lesion with OLP.
With regard to possible evolution and change of the 
clinical form of OLP, Carbone et al. (12) observed that 
15% patients manifested changes from red lesions to 
white ones with and without treatment. Furthermore, 
in a recent study, Chainani et al. (22) have described 
nine cases of oral leukoplakia in patients diagnosed 
previously of OLP, in a follow-up between two and ten 
years. Therefore, whether OLP can change their clinical 
form towards white type, the plaque-like form, the most 
frequent in our sample (71.4%) at the moment of diag-
noses, could be the starting point to take into account in 
the early diagnosis of PVL derivative from OLP. 
In addition, it is difficult to map and quantify the sub-
type given that OLP is very active in terms of its clini-
cal forms and extension (23), and because most of pa-
tients can have numerous locations (24). In this sense, 
we found the same prevalence in relation to location in 
buccal and gingival mucosa and all patients were affec-
ted in three or more areas, and one of those always was 
attached mucosa (gingival or palate). From this point 
of view, the location of attached mucosa may play an 
important role in early diagnosis of PVL.
Scientific literature evidences to confirm clinical OLP 
diagnosis is necessary to take a biopsy. Histological 
behaviour of the type of OLP that we described suffe-
red significant changes from the initial diagnosis until 
it became a multifocal verrucous form. A limitation of 
this study was the misinformation from each biopsy 
performed for individual patients, we have referred to 
first biopsy to diagnose OLP and the biopsy which his-
thologically confirmed PVL with predominated in the 
epithelium hyperkeratosis, or/and verrucous hyperpla-
sia, and SCC, and VC. All of the patterns shown in the 
study were based on the literature to diagnose of PVL 
(13,25).
Most authors emphasize that OLP treatment should fo-
cus on the symptom-based atrophic and erosive forms, 
considering that papule-reticular OLP does not require 
treatment (3). The first treatment option is a corticos-
teroid, although on reviewing the issue, it is stated that 
Fig. 2. The same woman three years later with papular-reticular and 
erosive lichen planus in hard palate. 
Fig. 3. Verrucous lichen planus in hard palate and left upper buccal 
sulcus in the same patient after eigth years from initial diagnosis. 
Fig. 4. The same patients, ten years after initial diagnosis of OLP and 
two years after fast-growing multifocal and verrucous, showing the 
clinical appearance of squamous cell carcinoma in the gingiva and 
left lower buccal sulcus. She also presented plaque OLP in gingiva, 
buccal and dorsum of the tongue.
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an effective treatment to cure OLP is lacking, and that 
no scientific evidence of a corticosteroid being more 
useful than any other in the topical treatment of OLP 
exists (26). The individualisation of the treatment was 
other of the limitations of our sample, given that on oc-
casions, recurrence or relapse was so common along 
with treatment resistance that some of the patients nee-
ded immediate action to switch and combine different 
alternatives. 
The use of topical retinoids was proposed for the reti-
cular and plaque-like OLP forms, and as an alternati-
ve to treatment with corticosteroids (27). One-third of 
PVL patients improved after an average of 5-6 months 
with topic or systemic retinoid therapy (28). We pro-
posed it orally and topically on two patients (cases 3 
and 12), with topical corticosteroid and CO2 laser the-
rapy applied during rest periods. CO2 laser vaporization 
has been proposed as a treatment alternative for erosive 
OLPs resistant to corticosteroid therapy (29), in plaque 
forms (30) and in PVL without dysplasia (14). CO2 la-
ser was the treatment for seven of our patient cases (in 
combination with other treatments), and four of them 
showed recurrence, that resistant to treatment was a 
cause for concern. This is another considerable diffe-
rence in treatment response between our proliferative 
verrucous form in OLP, and oral leukoplakia derived 
from OLP, described by Chainani-Wu et al. (22), becau-
se this oral leukoplakia treated with CO2 laser has been 
satisfactory evolution during their follow-up.
The potential for OLP to become malignant continues to 
be a very controversial issue, with its incidence fluctua-
ting between 0 and 3.5 percent (5). The progression from 
reticular forms to leukoplakia-type observed in our pa-
tients established that the malignant behaviour was very 
similar to that described previously in the PVL when it 
comes to occurring predominantly in women and located 
on the gum (13) and alveolar crest (31). It is estimated that 
the 70% of PVL goes onto become malignant (25) and 
a 28.5% figure was found among our cases. This could 
give rise to the thought that OLP that progresses towards 
the multifocal verrucous forms become malignant in the 
same proportion as verrucous leukoplakias (non-prolife-
rative) (32), and in a lower proportion than the proliferati-
ve verrucous leukoplakia (14).
Mignogna et al. (10) detected that almost all the forms of 
OLP that became malignant in their study were charac-
terised by presenting keratinous, reticular and plaque-
like areas. In line with this findings, we suggest that 
those clinical forms of OLP should be included in the 
progressive monitoring protocols and closely followed.
It is evident from other studies that OLP is seen more 
frequently in women and that long time series revealed 
that the use of tobacco and alcohol do not participate in 
the pathogenesis of OLP (12). For both reasons we do 
not recognise the sex, tobacco and alcohol as relevant 
factors in the early diagnosis of PVL developed from 
OLP. 
The term “multifocal”, has now been reused by Agui-
rre-Urizar (33) for more stringent referencing of early 
PVL diagnoses, and given the similarity of behaviour 
of these lesions in ours cases, it turns out to be very 
appropriate term to use for the description.
Given the usefulness of having some criteria to diagno-
se of PVL (17), we propose some clinical major, and his-
tological criteria, because the minor criteria indicated 
for PVL, predominantly female and non-smokers, may 
not be used as they are prevalent among the patients 
with OLP studied. On the basis of the above, we pro-
pose the following criteria to define this type of prolife-
rative multifocal OLP: 1) predominance of the plaque-
like form of OLP with thickening of the lesion at some 
point during the progression; 2) at least three affected 
topographical areas, given that two of them in symme-
try would already be included in the OLP diagnosis, 
highlighting the location in attached mucosa (gums and 
palate) 3) resistance to medical and surgical treatment, 
4) to remain during at least 5 years of monitoring those 
parameters; and 5) histological changes in the epithelial 
thickness (hyperkeratosis), verrucous hyperplasia, ve-
rrucous carcinoma or oral squamous cell carcinoma, a 
priori the most important criteria.
Conclusion
Based on the different percentage of malignance in our 
sample (28.5%) and the present in the literature review, 
from 40% to 74% of PVL, additional long-term research 
is necessary to clear if proliferative multifocal lichen 
planus and proliferative multifocal oral leukoplakia are 
the same disorder but have different behaviour of malig-
nancy for reasons of origin.
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